Skip to content

Multiple Myeloma in Combination with Bortezomib and Dexamethasone in Adult Patients Who Have Received At Least One Prior Treatment Regimen Including Lenalidomide

Products containing Pomalidomide feature in this group.

Pomalyst

Pomalidomide

4mg

Treats relapsed and refractory multiple myeloma by modulating the immune system and directly targeting tumour cells through cereblon binding, producing anti-proliferative, anti-angiogenic and immunomodulatory effects.

From$63.90/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.